Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Demoly

Showing results (121-130 of 367) with videos related to

Pageof 37
Sort By:
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|March 21, 2025
Anaphylaxis severity grade, during oral food challenges, assessed by five different classificationsYanis Bouderbala, Evangéline Clark, Luciana Kase Tanno, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 13, 2016
Drug hypersensitivity workup for suspected pristinamycin drug hypersensitivityRik Schrijvers, Katerina Lagara, Christine Breynaert, et al.
Vaccines|June 2, 2021
SARS-CoV-2 Vaccination and Anaphylaxis: Recommendations of the French Allergy Community and the Montpellier World Health Organization Collaborating CenterLuciana Kase Tanno, Frédéric Berard, Etienne Beaudoin, et al.
Contact Dermatitis|March 21, 2017
Occupational opiate contact dermatitisSophie Colomb, Jean L Bourrain, Nathalie Bonardel, et al.
Current Opinion in Allergy and Clinical Immunology|June 14, 2024
Drug allergy awareness and perspectives with the implementation of the International Classification of Diseases-11Luciana Kase Tanno, Yann Briand, Alain Perie, et al.
The World Allergy Organization Journal|April 16, 2024
Respiratory allergic diseases and allergen immunotherapy: A French patient survey before and during the COVID-19 pandemicPhilippe Devillier, Sarah Saf, Christine Rolland, et al.
Current Opinion in Allergy and Clinical Immunology|November 9, 2007
Immunotherapy: clinical trials--optimal trial and clinical outcomesPhilippe Jean Bousquet, Pascal Demoly, Giovanni Passalacqua, et al.
Current Opinion in Allergy and Clinical Immunology|July 19, 2022
Economic burden of drug-induced anaphylaxis: what can we do better?Barbara Cardoso, Teresa Moscoso, Mário Morais-Almeida, et al.
Respiratory Medicine|December 6, 2017
Implementation gaps for asthma prevention and controlLuciana K Tanno, Tari Haahtela, Moises A Calderon, et al.
The Journal of Allergy and Clinical Immunology|January 17, 2012
Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidenceMoisés A Calderón, Linda Cox, Thomas B Casale, et al.
Pageof 37

Showing results (121-130 of 367) with videos related to

Sort By:
Pageof 37
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|March 21, 2025
Anaphylaxis severity grade, during oral food challenges, assessed by five different classificationsYanis Bouderbala, Evangéline Clark, Luciana Kase Tanno, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 13, 2016
Drug hypersensitivity workup for suspected pristinamycin drug hypersensitivityRik Schrijvers, Katerina Lagara, Christine Breynaert, et al.
Vaccines|June 2, 2021
SARS-CoV-2 Vaccination and Anaphylaxis: Recommendations of the French Allergy Community and the Montpellier World Health Organization Collaborating CenterLuciana Kase Tanno, Frédéric Berard, Etienne Beaudoin, et al.
Contact Dermatitis|March 21, 2017
Occupational opiate contact dermatitisSophie Colomb, Jean L Bourrain, Nathalie Bonardel, et al.
Current Opinion in Allergy and Clinical Immunology|June 14, 2024
Drug allergy awareness and perspectives with the implementation of the International Classification of Diseases-11Luciana Kase Tanno, Yann Briand, Alain Perie, et al.
The World Allergy Organization Journal|April 16, 2024
Respiratory allergic diseases and allergen immunotherapy: A French patient survey before and during the COVID-19 pandemicPhilippe Devillier, Sarah Saf, Christine Rolland, et al.
Current Opinion in Allergy and Clinical Immunology|November 9, 2007
Immunotherapy: clinical trials--optimal trial and clinical outcomesPhilippe Jean Bousquet, Pascal Demoly, Giovanni Passalacqua, et al.
Current Opinion in Allergy and Clinical Immunology|July 19, 2022
Economic burden of drug-induced anaphylaxis: what can we do better?Barbara Cardoso, Teresa Moscoso, Mário Morais-Almeida, et al.
Respiratory Medicine|December 6, 2017
Implementation gaps for asthma prevention and controlLuciana K Tanno, Tari Haahtela, Moises A Calderon, et al.
The Journal of Allergy and Clinical Immunology|January 17, 2012
Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidenceMoisés A Calderón, Linda Cox, Thomas B Casale, et al.
Pageof 37